Clinical Characteristics and Healthcare Resource Utilization for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review

Background: Mucopolysaccharidosis II (MPS II; Hunter syndrome) is a rare, X-linked, life-limiting lysosomal storage disease characterized by a deficiency in the activity of the enzyme iduronate-2-sulfatase. Accumulation of glycosaminoglycans in tissues and organs throughout the body causes cellular...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayodele, Olulade, Müller, Kersten, Setayeshgar, Solmaz, Alexanderian, David, Yee, Karen S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2022
Materias:
Hereditary Genetic Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098230/
https://www.ncbi.nlm.nih.gov/pubmed/35620452
http://dx.doi.org/10.36469/jheor.2022.33801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098230/
https://www.ncbi.nlm.nih.gov/pubmed/35620452
http://dx.doi.org/10.36469/jheor.2022.33801

Ejemplares similares